Serum Bile Acid Profile in Patients with Inflammatory Bowel Disease
10.3969/j.issn.1008-7125.2017.05.009
- VernacularTitle:炎症性肠病患者血清胆汁酸谱的研究
- Author:
Xiajuan LU
;
Min ZHOU
;
Chunying QU
;
Wensong GE
;
Yingwei CHEN
- Keywords:
Bile Acids and Salts;
Inflammatory Bowel Disease;
Colitis;
Ulcerative;
Crohn Disease
- From:
Chinese Journal of Gastroenterology
2017;22(5):297-300
- CountryChina
- Language:Chinese
-
Abstract:
Background: The incidence of inflammatory bowel disease (IBD) is increasing in recent years, and the etiology and pathogenesis of IBD remain unclear.Studies showed that disorder of bile acid metabolism plays an important role in the pathological process of experimental colitis.However, serum bile acid profile in IBD patients has not been reported.Aims: To investigate the changes of serum bile acid profile in patients with IBD.Methods: Seven healthy controls, 15 patients with ulcerative colitis (UC) and 16 patients with Crohn's disease (CD) at Shanghai Xin Hua Hospital were enrolled.High-performance liquid chromatography-mass spectrometry was used to determine serum bile acid profile.Results: No significant differences in serum concentrations of primary bile acid cholic acid (CA), chenodeoxycholic acid (CDCA), glycocholic acid (GCA), taurocholic acid (TCA), glycochenodeoxycholic acid (GCDCA) were found between UC or CD and controls (P>0.05).Compared with controls, serum concentration of secondary bile acid deoxycholic acid (DCA) in UC patients was significantly decreased (P<0.05), glycodeoxycholic acid (GDCA), taurodeoxycholic acid (TDCA) in CD patients were significantly decreased (P<0.05), serum concentration of lithocholic acid (LCA) in UC and CD patients was significantly decreased (P<0.05).Conclusions: The serum bile acid profile in IBD patients is significantly changed, which suggests that it may be involved in the pathological process of IBD.
